Cigna Ventures

Founded 2018

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 11
Rounds per year 3.67
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Key employees Soon

Areas of investment

  • Health Care
  • Information Technology
  • Medical
  • Wellness
  • Software
Summary

The fund was located in North America if to be more exact in United States. Cigna Ventures appeared to be a CVC structure as part of the corporation. The main office of represented VC is situated in the Bloomfield.

The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Therapeutics, Analytics. Among the various public portfolio startups of the fund, we may underline Omada Health, GNS Healthcare, Buoy Health Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 1 or 5+ of the founder, the probability for it to get the investment is little.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Cigna Ventures, startups are often financed by U.S. Venture Partners (USVP), Norwest Venture Partners, Designer Fund. The meaningful sponsors for the fund in investment in the same round are Wellington Management, U.S. Venture Partners (USVP), Sanofi-Genzyme BioVentures. In the next rounds fund is usually obtained by Intermountain Ventures.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cricket Health

Health Care
$83M05 Aug 2021 Boston, Massachusetts, United States

Cleerly

Apps
Artificial Intelligence
Education
Health Care
Information Technology
Medical
$43M21 Jun 2021 New York, New York, United States

Octave

Health Care
Personal Health
Wellness
$20M25 May 2021 San Francisco, California, United States

Buoy Health

Apps
Health Care
Information Technology
Internet
$37M10 Nov 2020 Boston, Massachusetts, United States

Datavant

Big Data
Biopharma
Clinical Trials
Data Integration
Health Care
Software
$40M08 Oct 2020 San Francisco, California, United States

Ginger

Automotive
Electric Vehicle
Fitness
Health Care
mHealth
Mobile
Wellness
$50M06 Aug 2020 San Francisco, California, United States

AristaMD

Business/Productivity Software
Consulting Services (B2B)
Health Care
Hospital
Managed Care
mHealth
Other Healthcare Technology Systems
Software
$18M31 Mar 2020 San Diego, California, United States

Arcadia io

Health Care
Information Services
Information Technology
Software
$29M13 Jan 2020 Massachusetts, United States

RecoveryOne

Health Care
Information Services
Medical
$12M17 Dec 2019 California, United States
News
Zerigo Health Raises $43 Million in Series B Funding to Drive Adoption of the Industry’s Only Connected Light Therapy Solution to Treat Chronic Skin Conditions

– Zerigo Health announced a $43m Series B investment led by 7wireVentures, joined by General Catalyst, Dragoneer, Cigna Ventures, Leverage Health Solutions, and Leaps by Bayer.
– The round also included participation by existing investors including SV Health Investors, H.I.G. Capital, and Bluestem Capital.
– This round will allow Zerigo Health to respond to the increasing demand for its innovative connected chronic skin condition solution for the over 40 million Americans living with psoriasis, vitiligo, and eczema.
– Glen Tullman, Managing Partner of 7wireVentures, former Founder and CEO of Livongo, and Chief Executive Officer of Transcarent, will join as Executive Chairman of the company’s Board of Directors.

Tritium Announces AUD$40 million Private Placement Financing by Cigna Investments, Inc.

– Tritium Holdings Pty Ltd (“Tritium”), a global developer and manufacturer of direct current (“DC”) fast charging technology for electric vehicles (“EVs”), announced a AUD$40 million private placement.
– The round was led by Cigna Investments, the investment arm of Cigna Corporation, a U.S.-based global health services company.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cigna Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: